N-[4-[3-(5-chlorothiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-2-pyridinyl]-2-(4-fluorophenyl)acetamide
C24H16ClFN4OS — CID 162687604
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[3-(5-chlorothiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-2-pyridinyl]-2-(4-fluorophenyl)acetamide
N-[4-[3-(5-chlorothiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-2-pyridinyl]-2-(4-fluorophenyl)acetamide (PubChem CID 162687604) has the molecular formula C24H16ClFN4OS and a molecular weight of 462.94 g/mol. Its IUPAC name is N-[4-[3-(5-chlorothiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-2-pyridinyl]-2-(4-fluorophenyl)acetamide.
Molecular Properties
| Compound Name | N-[4-[3-(5-chlorothiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-2-pyridinyl]-2-(4-fluorophenyl)acetamide |
|---|---|
| PubChem CID | 162687604 |
| Molecular Formula | C24H16ClFN4OS |
| Molecular Weight | 462.94 g/mol |
| Exact Mass | 462.07 |
| IUPAC Name | N-[4-[3-(5-chlorothiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-2-yl]-2-pyridinyl]-2-(4-fluorophenyl)acetamide |
| SMILES | O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(Cl)s2)ccn1 |
| InChI | InChI=1S/C24H16ClFN4OS/c25-19-8-7-18(32-19)22-23(29-17-2-1-10-28-24(17)22)15-9-11-27-20(13-15)30-21(31)12-14-3-5-16(26)6-4-14/h1-11,13,29H,12H2,(H,27,30,31) |
| InChIKey | USMHWTKVCMQLRC-UHFFFAOYSA-N |
| XLogP | 6.33 |
| TPSA | 70.67 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 462.94 |
| LogP ≤ 5 | 6.33 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162687604 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.